Molecular typing and biofilm characterization of pseudomonas aeruginosa isolated from clinical samples in Lebanon. (c2011) by Timani, Rola J.
   
LEBANESE AMERICAN UNIVERSITY 
 
 
 
 
 
Molecular Typing and Biofilm Characterization of Pseudomonas 
aeruginosa Isolated from Clinical Samples in Lebanon 
 
 
By 
  
 
Rola J. El-Timani 
 
 
 
 
A thesis submitted in partial fulfillment of the 
requirements for the degree of Master of Science 
in Molecular Biology  
 
 
 
School of Arts and Sciences 
July 2011 
 
ii 
 
 
iii 
 
 
iv 
 
 
v 
 
ACKNOWLEDGEMENTS 
 
 
I am heartily thankful to my supervisor, Dr. Sima Tokajian, whose guidance and support 
from the initial to the final level enabled me to develop an understanding of the subject.  
 
I would like to show my gratitude to Dr. Brigitte Wex and Dr. Roy Khalaf for their time 
and their willingness to be members of the committee. I am also thankful to Mrs. Helena 
Bou Farah, Maya Farah, and the genomic lab technicians, Sonia Youhanna and Mark 
Haber, for their valuable assistance.  
 
I offer my regards and blessings to all of those who supported me in any respect during the 
completion of the project, especially my trainers Wissam Khalil and Wael Bahnan, and my 
helpful friends Houda Harastani, Nathalie Karaky, and Khaled Abdallah. Thanks to all my 
colleagues who made my experience at LAU memorable.  
 
Lastly, I would like to give my heartfelt appreciation to my parents, who brought me up 
with their love and encouraged me to pursue advanced degrees. It is a pleasure too, to 
express my admiration to my brother, Rami, and my sister, Sarah, for their understanding 
and support. 
 
 
 
 
 
 
 
vi 
 
 
 
 
 
 
 
 
To My Parents, 
I Dedicate This Work… 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
ABSTRACT 
 
Molecular Typing and Biofilm Characterization of Pseudomonas 
aeruginosa Isolated from Clinical Samples in Lebanon 
 
By 
 
 Rola J. El-Timani 
 
 
Pseudomonas aeruginosa is a gram-negative rod that can cause severe infections which are 
associated with high mortality rates in immunocompromised patients. It is a frequent cause 
of nosocomial infections where the spread of organisms is a common source of outbreaks. 
One of the clinical significance of P. aeruginosa is its ability to form a biofilm on living or 
non-living tissues and to differentiate into layered structures of sessile multicellular 
bacterial cells bound by exopolysaccharide matrix (EPS). The genome size of P. 
aeruginosa varies from 5.2 to 7.1 Mbp. This degree of variation highlights the importance 
of typing methods used to study the evolution and epidemiology of this organism. This 
study aimed at typing 100 clinical P. aeruginosa isolates recovered from several site of 
infections obtained from American University of Beirut Medical Center (AUBMC). The 
relatedness of the isolates was inspected by aligning their PFGE types (PT) in a 
dendrogram. The phylogenetic tree revealed the presence of two major groups (I and II), 
one of which contained only 2 isolates. The second major group (II) consisted of 8 
subgroups (represented from A to H) with C, F, G and H being further divide into 2 clones 
each. None of the isolates were genetically identical with 100% similarity index. A strong 
correlation was detected between respiratory tract P. aeruginosa strains and the cluster II-G 
of certain restriction patterns. In addition to a moderate correlation between urine samples 
and PFGE cluster II-C. Antimicrobial susceptibility testing showed the distribution of the 
P. aeruginosa samples into 32 antibiotypes. Tetracycline was considered an ineffective 
drug against P. aeruginosa due to the high resistance percentage (95%), followed by 
carbenicillin (49%). The most effective antibiotic was imipenem due to the least percentage 
of resistance (20%), followed by ceftazidime (23%). Another objective of this study was to 
viii 
 
investigate the presence of a relationship between the strength of attachment of P. 
aeruginosa to stainless steel surfaces and their corresponding antibiotic susceptibility 
profile. A weak correlation has been detected between multiple drug resistance and strength 
of attachment to surfaces. Significance of such a result is that even antibiotic susceptible P. 
aeruginosa could have the potential of attaching strongly to surfaces and hence forming 
biofilm. This study showed the importance of PFGE in characterizing the genetic diversity 
and assessing the risk of environmental reservoirs of P. aeruginosa and the banding 
patterns established will serve as a database to better understand the evolutionary 
epidemiology of this important human pathogen in Lebanon.  
  
 
Keywords: P. aeruginosa, Molecular typing, PFGE, Biofilm formation, Antibiotic 
resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
 
TABLE OF CONTENTS 
 
 
Chapter 
 
1. INTRODUCTION        1-2  
 
2. LITERATURE REVIEW       3-9  
 
2.1 Overview on Pseudomonas aeruginosa      3 
2.2 Clinical Significance   3 
2.3 Virulence Factors         5 
2.4 Biofilm Formation         6 
2.5 Antibiotic Resistance of P. aeruginosa      7 
2.6 Molecular Typing of P. aeruginosa       8 
 2.6.1 Pulsed-Field Gel Electrophoresis (PFGE)     9 
     
  
3. MATERIALS AND METHODS              10-12 
 
3.1. Clinical Isolates         10 
3.2. Molecular Typing of P. aeruginosa by PFGE      10 
3.2.1 Dendrogram and PFGE pattern analysis                               11 
 3.3 Antibiotic Susceptibility Test        11 
 3.4 Biofilm Formation of P. aeruginosa                      11 
 3.4.1 Preparation of P. aeruginosa suspensions     11 
 3.4.2 Preparation of test surfaces       12 
 3.4.3 Measuring the attachment strength                                        12 
 
4. RESULTS                   13-20  
 
x 
 
4.1 Antibiotic Susceptibility Test        13  
4.1.1 Resistance versus Site of Infection      13 
4.1.2 Resistance versus Presence of exoS and exoU     14 
 
4.2 Strength of Attachment                   14 
4.3 PFGE and Dendrogram Analysis                  14 
4.4 Biotypes          15 
                                
 
5. DISCUSSION                  21-26 
 
6. CONCLUSION                  27-28  
 
7. BIBLIOGRAPHY                  29-36  
 
 
8. ANNEX                   37-50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xi 
 
LIST OF TABLES 
 
 
 
Table           Page 
 
Table 1          19 
Distribution of P. aeruginosa isolates among the 2 major PFGE 
groups (I and II) and subgroups (A to H) based on the site of 
infection (tracheal aspirates, sputum, urine, and pus), and detected 
exotoxins genes (exoS and exoU). 
 
Annex 1           37 
Demographics of the 100 P. aeruginosa clinical isolates collected 
from American University of Beirut Medical Center (AUBMC). 
 
 
Annex 2          42 
Antibiotic susceptibility profiles for the 100 clinical isolates of P. 
aeruginosa and their antibiotypes. 
 
 
Annex 3           45 
Antibiotic susceptibility profile of each of the 32 antibiotypes and the 
percentage of isolates belonging to each antibiotype. 
 
Annex 4          46 
Blot succession technique results of the 100 clinical isolates of P. aeruginosa. 
 
 
Annex 5          50 
Distribution of the isolates in the different biotypes based on their 
morphological characteristics. 
 
 
 
 
 
 
 
 
 
 
xii 
 
LIST OF FIGURES 
 
 
 
Figure           Page 
         
 
Figure 1           16 
Percentage of P. aeruginosa isolates that are resistant to each of 
the 6 antibiotics tested, imipenem (IPM), carbenicillin (CAR), 
piperacillin/tazobactam (TZP), tetracycline (TE), aztreonam 
(ATM), and ceftazidime (CAZ), by measuring the inhibition zone 
of the disc diffusion susceptibility test. 
 
Figure 2           16 
Distribution of multidrug resistance among P. aeruginosa clinical 
isolates. 
 
Figure 3          17 
Distribution of infection sites of the P. aeruginosa isolates that are 
multidrug resistant to more than 1 antibiotic tested. 38% were 
recovered from tracheal aspirates, 16% from urine, 13% from 
sputum, 11% from each of wound and pus, 3.5% from each of bile 
and ear, and 2% from each of catheter and bronchial washing. 
 
Figure 4           17 
Percentage of resistant isolates harboring exoS or exoU as a 
function of number of antibiotics they are resistance to. 
 
Figure 5          18 
Number of colonies grown as a function of plate succession 
number for 3 isolates (PA4, PA124, and PA154) selected as an 
example of variation in strength of attachment of P. aeruginosa 
strains. 
 
Figure 6           18 
PFGE gel displaying restriction patterns of 10 representative P. 
aeruginosa clinical isolates, PA 29, PA 32, PA 34, PA 36, PA 37, 
PA 43, PA 44, PA 45, PA 47 and PA 51 cut by SpeI. Lanes 1, 7, 
and 13 represent BioLab Lambda marker that has a size range of 
48.5 kb to 1,018.5 kb. 
 
 
 
xiii 
 
 
 
Figure 7           19 
Dendrogram of PFGE patterns of P. aeruginosa isolates generated 
with the Gel Compar II software showing two major groups (I and 
II), where (I) contained 2 isolates. The second major group (II) 
consisted of 8 subgroups (A to H) where C, F, G and H further 
divide into 2 clones each (C1, C2, F1, F2, G1, G2, H1 and H2). 
The scale indicates percent similarity. 
                  
 
Figure 8          20 
Dendrogram of PFGE macrorestriction patterns of P. aeruginosa 
isolates generated with the Gel Compar II software. The scale 
indicates percent similarity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
GLOSSARY 
 
ATCC: American Type Culture Collection 
ATM: aztreonam 
bp: base pair  
CAR: carbencillin 
CAZ: ceftazidime 
CF: cystic fibrosis 
CFU: colony forming unit 
CLSI: Clinical and Laboratory Standards Institute 
DNA: deoxyribonucleic acid   
EPS: exopolysaccharide matrix 
EtBr: ethidium bromide 
FEP: cefepime 
HSL: homoserine lactones 
ICU: intensive care unit 
IPM: imipenem 
LPS: lipopolysaccharides 
MBL: metallo-β-lactamase 
MDR: multidrug resistant 
MLST: multi-locus sequence typing 
P. aeruginosa: Pseudomonas aeruginosa 
PCR: polymerase chain reaction  
PFGE: pulse-field gel electrophoresis 
PKPD: pharmacokinetics/pharmacodynamics   
PT: PFGE type 
TBE: tris-borate EDTA 
TE: tetracycline 
TSA: Tryptone Soy Agar 
TSB: Tryptone Soy Broth  
xv 
 
TZP: pipercillin/tazobactam  
ST: sequence type 
TLR: toll-like receptor
UTI: urinary tract infections 
VAP: ventilator-associated pneumonia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter One 
 
INTRODUCTION 
 
P. aeruginosa is a ubiquitous Gram-negative opportunistic pathogen that has the ability to 
survive in a wide range of natural reservoirs (Fito-Boncompte et al., 2011). P. aeruginosa 
is engaged in many types of human infections in community and mainly in health care 
settings, where this pathogen causes 200,000 hospital-acquired infections each year in the 
United States (Kapoor et al., 2011; Ivanov et al., 2011). Eighty percent of cystic fibrosis 
(CF) patients are infected with P. aeruginosa, knowing that CF patients along with the 
immunocomprimised are more vulnerable to sepsis and pneumonia caused by this pathogen 
(Bridier, Dubois-Brissonnet, Thomas, & Briandet, 2011; Kapoor et al., 2011). In addition, 
P. aeruginosa can commonly infect contact lens consumers causing corneal ulceration as it 
contaminates moist areas (Stewart et al., 2011). 
 
An important characteristic of P. aeruginosa is its capability to confer resistance to several 
classes of antibiotics exacerbating the threat of such organism (Kapoor et al., 2011; Tian, 
Adams-Haduch, Bogdanovich,, Wang, & Doi, 2011). Intrinsic mechanisms of antimicrobial 
tolerance include the expression of β-lactamases and efflux pumps, and decreased 
permeability of the outer membrane. Other mechanisms involve acquisition of transferable 
resistance determinants, such as genes coding for enzymes that inactivate aminoglycosides 
or alter their targets, and genes for β-lactamases (Tian et al., 2011). Consequently, the 
increased occurrence of antibiotic resistance has created a critical necessity to discover 
pharmaceutical candidates that could substitute existing treatments of P. aeruginosa 
(Kapoor et al., 2011).  
 
Bacterial motility facilitates surface colonization and the spread of bacteria across the 
surface. P. aeruginosa can undergo the flagellum-mediated swimming motility through 
hyperflagellation as well as surface-associated swarming and twitching motilities mediated 
by type-IV pili. Such motilities enhance biofilm formation which is a heterogenously 
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structured, surface-associated bacterial community (O’May & Tufenkji, 2011). In turn, P. 
aeruginosa biofilms contribute to higher resistance to antimicrobial treatments than their 
planktonic counterparts. Therefore, the prevention of bacterial surface contamination is a 
principle concern of public health (Bridier et al., 2011). 
 
Molecular typing approach of P. aeruginosa has become important in identifying cross-
infections in hospitals and specifically in CF centers, thus helping to control transmission 
means. There are many factors to consider when selecting a molecular typing technique, 
including discriminatory power, typeability, reproducibility, cost, simplicity and logistics. 
Pulsed-field gel electrophoresis (PFGE) has a high discriminatory power making it a 
reliable standard for DNA fingerprinting of isolates to identify or confirm outbreak 
situations. Single mutations can generate or eliminate restriction sites causing considerable 
changes in PFGE banding patterns, hence the outcome of genotyping (Kidd, Grimwood, 
Ramsay, Rainey, & Bell, 2011).  
 
In this study, we report on the molecular typing and characterization of 100 P. aeruginosa 
isolates by performing PFGE technique and correlating the results to resistance to 6 
antimicrobial agents. The isolates were collected from American University of Beirut 
Medical Center (AUBMC) in Lebanon, from several tissues of patients of all age ranges 
during 2007. We also report on the potential of these isolates to attach to surfaces, 
specifically stainless steel, and correlate them to antibiotic resistance.  
 
The major objectives of this study were (i) to test the antimicrobial susceptibility of P. 
aeruginosa clinical isolates to 6 antibiotics using disk diffusion, (ii) to identify and 
characterize P. aeruginosa strains by PFGE, (iii) to study the relatedness of the strains 
through dendrogram analysis, (iv) to inspect the presence of a relationship between 
genotypic profiles and antibiotic resistance, and (v) to correlate the strength of attachment 
of P. aeruginosa to stainless steel surfaces to their drug resistance. 
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Chapter Two 
 
LITERATURE REVIEW 
 
 
2.1 Overview on Pseudomonas aeruginosa  
 
 
Pseudomonas aeruginosa is a gram-negative, motile, extracellular, aerobic, and rod-shaped 
bacterium that is able to consume a broad range of organic compounds. It is ubiquitous in 
the natural environmental settings for it can be isolated from different living organisms 
comprising plants, animals, and humans (Curran, Jonas, Grundmann, Pitt, & Dowson, 
2004; Lister, Wolter, & Hansoni, 2009).  
 
The history of P. aeruginosa begins in 1850 when Se’dillot was first to recognize that a 
transmissible agent was responsible for the bluish-green color of surgical wound bandages. 
In 1860, Fordos extracted the pyocyanin pigment that gives such coloration, while Lucke 
associated the pigment with a rod-shaped organism in 1862. However, it was not until 1882 
when P. aeruginosa was first described as a pathogen in France by Carle Gessard where he 
isolated the organism, under its initial name Bacillus pyocyaneus, from two patients having 
cutaneous wounds with bluish-green pus (Lister et al., 2009). This explains the original 
name for bacillus meaning rod, pyo referring to pus, and cyaneous being blue. Yet, the 
present name means that this etiologic unit of infection (monad) has resemblance (pseudo) 
to green or copper-like shapes (aeruginosa) (Villavicencio, 1998). 
 
 
2.2 Clinical Significance 
 
 
P. aeruginosa can survive on minimal nutritional needs and stand different physical 
conditions allowing it to thrive in community as well as hospital settings. In the 
community, P. aeruginosa strains can be isolated from swimming pools, contact lens 
solutions, hot tubs, home humidifiers, soil, vegetables, or any moist environment. Such 
strains are non-resistant and can cause community-acquired infections that are usually self-
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limiting. However, the most common serious infections are due to multidrug resistant 
(MDR) P. aeruginosa strains that inhabit hospital reservoirs including disinfectants, 
antiseptics, soaps, sinks, eye drops, dialysis fluids,  medicines, aerators, respiratory therapy 
equipment, physiotherapy and hydrotherapy pools. These sources help in the spread of 
MDR P. aeruginosa in outbreaks (Curran et al., 2004; Paterson, 2006; Lister et al., 2009). 
 
As a human pathogen, P. aeruginosa is the principal source of gram-negative nosocomial 
infections with high morbidity and mortality. It is a common cause of acute infections, such 
as corneal trauma, extensive wounds and burns, catheter-related bladder injury, urinary 
tract infections (UTI), sepsis and severe pneumonia. The risk of P. aeruginosa pneumonia 
is increased in immunosuppressed patients or those who require mechanical ventilation 
knowing that P. aeruginosa is the leading cause of ventilator-associated pneumonia (VAP). 
Furthermore, around 20% of pneumonia conditions in intensive care units (ICU) are due to 
P. aeruginosa (Bucior, Mostov, & Engel, 2010; Diaz & Hauser, 2010) 
 
Cystic fibrosis (CF) patients are much more susceptible to P. aeruginosa where 90% of CF 
patients have chronic lung infections due to colonization of P. aeruginosa. This organism is 
hardly eliminated from CF lungs causing reduced pulmonary function and thus life 
expectancy (Tingpej et al., 2007; Hannauer, Barda, Mislin, Shanzer, & Schalk, 2010; Kidd 
et al., 2009). A recent surveillance study showed that P. aeruginosa is responsible of 30% 
of pneumonias, 19% of UTI, and 10% of bloodsream infections (Lister et al., 2009). 
 
There is a critical therapeutic challenge with P. aeruginosa associated with community-
acquired and most importantly hospital-acquired infections. It is necessary to select the 
proper antibiotic upon the start of the therapy in order to achieve an optimal clinical 
outcome. Nevertheless, not only P. aeruginosa has the ability to develop resistance to 
antimicrobial agents of diverse classes, but also resistance may emerge during the course of 
infection therapy. MDR P. aeruginosa are associated with higher morbidity rates, 
requirement of surgery, longer hospital stay, and increased cost of chronic care of the 
patient. The strategy by which P. aeruginosa develops resistance to antibiotics is through 
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acquiring resistance genes on mobile genetic elements. Another mechanism involves 
mutations that affect the function or expression of processes encoded on the chromosome 
(Micek et al., 2005; Lister et al., 2009).  
 
 
2.3 Virulence Factors 
 
 
Many cell-associated and extracellular virulence factors of P. aeruginosa are responsible 
for its pathogenicity. Some of the virulence factors include cytotoxins ExoU and ExoS, 
alkaline protease, protease IV, and elastase B, which are encoded by exoU, exoS, aprA, 
prpL, and lasB respectively. The type III secretion system of exoU contributes to cytotoxic 
phenotype, whereas that of exoS gives invasive phenotype (Choy, Stapleton, Willcox, & 
Zhu, 2008). In addition, the virulence of ExoU is expressed by its phospholipase A2 
activity where it targets the plasma membrane, cleaves membrane phospholipids, and 
consequently lyses the host cell completely and rapidly (Diaz & Hauser, 2010). Proteases 
can damage connective tissue and degrade host immunological factors. Such functions of 
virulence factors influence corneal infection and visual disability known as Pseudomonas 
keratisis (Choy et al., 2008).  
 
Another virulence factor is the single polar glycosylated flagellum of P. aeruginosa. The 
function of flagella is not limited to motility, but also they have a role in activating host 
inflammatory response through Toll-like receptor 5 (TLR5) and in attaching bacteria to 
host cells. A major protein constituent of the flagellar filament is the flagellin that can be 
classified into a and b serotypes which serve as target antigens for vaccination 
(Campodonico et al., 2010). 
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2.4 Biofilm Formation 
 
 
P. aeruginosa is a critical example of the clinical significance of biofilm of microbes. P. 
aeruginosa biofilms form, when communities of bacteria attach to surfaces where nutrients 
are available and differentiate into layered structures of sessile multicellular bacterial cells 
bound by exopolysaccharide matrix (EPS) (Shih & Huang, 2002; Banin, Vasil, & 
Greenberg, 2005; Goodman, 2010). Biofilm formation can occur on living or non-living 
tissues, mucosa and implanted medical devices causing lung infections, ventilator-
associated pneumonia, and catheter infections (Fazli et al., 2009; Goodman, 2010).  
 
There are differences in the characteristics between bacterial cells in biofilms and those in 
planktonic form. The most important characteristic of bacteria in biofilm is displaying 
higher resistance to antibiotics and to host immune responses (Wozniak et al., 2003; Fazli 
et al., 2009). Not only do P. aeruginosa biofilms have antibiotic resistance, but also they 
play a role in transferring such resistance to new bacterial cells, and in damaging materials 
(Shih & Huang, 2002). Bacterial biofilms can deeply colonize chronic wounds, thus 
impeding proper wound healing (Fazli et al., 2009). Therefore, it is important to study the 
molecular mechanisms of P. aeruginosa inter-cellular communication in biofilm formation 
in order to understand its pathogenicity and to develop unconventional drug treatment 
(Cornelis, 2008).  
 
P. aeruginosa biofilm formation is mediated by the activation of certain genes that are 
dependent on cell density. This cell-to-cell communication is referred to as quorum 
sensing, and was first explained by Davies et al., (1998), where bacterial cells secrete 
homoserine lactones (HSL) signals in order to activate certain genes. The two HSL signals 
involved in this quorum sensing process of P. aeruginosa biofilm formation are 3OC12-
HSL and C4-HSL encoded by lasI and rhlI genes respectively (Davies et al.,, 1998; Shih & 
Huang, 2002). 3OC12-HSL is recognized by the regulator protein LasR whereas C4-HSL is 
recognized by RhlR. When both acyl-HSL reach a certain threshold concentration, their 
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regulators LasR and RhlR consequently, express genes encoding virulence factors (Thaden, 
Lory, & Gardner, 2010).    
 
Various cellular pathways are associated with the two acyl-HSL systems. One essential 
pathway is the oxidative stress response where quorum sensing in biofilms upregulates 
genes, such as Mn-cofactored superoxide dismutase (sodA), Fe-cofactored superoxide 
dismutase (sodB), and catalase (katA). In addition, such quorum sensing can increase 
bacterial tolerance to hydrogen peroxide (Harrison, Ceri, & Turner, 2007; Thaden et al., 
2010).  
 
 
2.5 Antibiotic Resistance of P. aeruginosa 
 
 
Antimicrobial resistance has limited the chances of therapeutic alternatives and is a 
considerable challenge to bacteriologists (Su et al., 2010; Tam et al., 2010). Polymyxin E is 
now used as a savior therapy against P. aeruginosa infections, especially after the 
increasing resistance to most accessible antibiotics. Polymyxin molecules act on Gram-
negative bacteria by displacing Mg
2+
 and Ca
2+
 ions that are present between the negatively 
charged lipopolysaccharides (LPS) of the outer membrane. However, P. aeruginosa has 
adapted to the new conditions and consequently developed a resistance mechanism against 
polymyxin by increasing Mg
2+
 and Ca
2+
 concentrations to an extent that competes and 
inhibits the effect of the antibiotic. Therefore, the significance of optimizing the 
pharmacokinetics/pharmacodynamics (PKPD) of antimicrobials is proposed to overcome 
infections successfully (Bulitta et al., 2010).  
 
Similarly, Cefepime (FEP) and ceftazidime (CAZ), which belong to the cephalosporins, 
show reduced efficacy over P. aeruginosa due to development of resistance mechanisms. 
Some of those mechanisms include increased efflux, derepression of the chromosomal 
AmpC ß-lactamase, and the impermeability of the outer membrane (Pena et al., 2009; 
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Tomas et al., 2010). AmpC regulation is closely associated to peptidoglycan recycling 
(Zhang et al., 2010). Additionally, metallo-β-lactamase (MBL)-producing P. aeruginosa 
strains are becoming of serious concern due to the high mortality rates they cause especially 
after an improper empirical therapy. MBL can be acquired through plasmids carrying MBL 
genetic elements, a fact that makes recognition and prevention of intra- and interhospital 
propagation an important goal (Qu et al., 2009). On the other hand, carbapenems are 
classified as last-resort drugs for treating multidrug-resistant P. aeruginosa infections 
(Tsakris et al., 2009; Layeux, Taccone, Fagnoul, Vincent, & Jacobs, 2010). Mechanisms of 
resistance to carbapenems have emerged in P. aeruginosa strains, such as the production of 
carbapenem-hydrolyzing β-lactamases. Aztreonam is the only β-lactam antibiotic that is 
saved from the activity of β-lactamases (Tsakris et al., 2009). Although understanding 
about antibacterial resistance has been gained, it is apparent that much is needed to learn 
about how this resourceful pathogen regulates diverse resistance mechanisms each 
corresponding to the different antibacterial activities it faces (Lister et al., 2009). 
 
 
2.6 Molecular Typing of P. aeruginosa 
 
 
The threat of resistant P. aeruginosa to ICU patients encourages the development of typing 
methods for this organism. P. aeruginosa typing would determine how related nosocomial 
pathogens are to each other and to discriminate whether the infection is due to patient-to-
patient transmission or endogenous strains. Furthermore, epidemiologists would benefit 
from microbial typing for the study of proper infection control measures (van Belkum et 
al., 2007; Johnson, Arduino, Stine, Johnson, & Harris, 2007). Clinical laboratories rely on 
non-expensive and rapid procedures such as antibiotic susceptibility or biochemical tests, 
which are used for identification purposes. Biochemical tests, along with production of 
pigment and hemolysis allow the determination of different biotypes. P. aeruginosa has a 
standard response to some biochemical tests. However, this response may vary with other 
tests providing different profiles or biotypes that are useful to discriminate clinical isolates. 
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Most P. aeruginosa strains produce pyocyanin and fluorescein, which gives colonies their 
characteristic blue-green color in agar cultures. Other P. aeruginosa colonies may have 
distinct color due to other pigments or may be non-pigmented (Freitas & Barth, 2004). 
Nevertheless, further molecular typing of multi-drug resistant nosocomial pathogens 
facilitates discovering hidden reservoirs and the distribution of potential outbreak clones in 
other wards (Crivaro et al., 2009; Ratkai et al., 2010). Therefore, molecular typing such as 
pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) are a 
more reliable and accurate method (Deplano et al., 2005).   
 
 
2.6.1 Pulsed-Field Gel Electrophoresis (PFGE) 
 
 
PFGE has the power to resolve DNA fragments of large sizes by alternating voltages in 
different directions. This is achieved by macrorestriction analysis without the use of 
hybridization labeled probes. PFGE remains the “gold standard” and widespread genotypic 
method for fingerprinting and comparing isolates because it utilizes more than 80% of the 
chromosomal DNA to produce the molecular profiles of bacteria (Woodford & Johnson, 
1998; Curran et al.,, 2004). PFGE procedure involves embedding the organisms in agarose, 
lysing them in situ, and partial digestion of chromosomal DNA with restriction 
endonuclease. The chromosomal DNA fragments contained in agarose are loaded into the 
wells of an agarose gel, and the restriction fragments are set into a pattern of distinct bands 
by an electrophoresis apparatus that switches the direction of current (Tenover et al., 1995). 
The band patterns are compared through the Dice coefficient by using the unweighted pair 
group method to determine band similarity and to define the pulsed-field type clusters. 
Isolates with band patterns that are 100% identical are considered to be of identical PFGE 
types, and isolates that had band patterns with ≥87% similarity are considered to be 
genetically related (Johnson et al., 2007).  
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Chapter Three 
 
MATERIALS AND METHODS 
 
 
 
3.1 Clinical Isolates  
 
 
A total of 100 P. aeruginosa isolates obtained from clinical specimens in the period 
between March and November of 2007 kindly provided by Dr. George Araj from American 
University of Beirut Medical Center (AUBMC) were used in this study. The isolates were 
mainly recovered from tracheal aspirates (28%), urine (21%), sputum (16%), pus (11%), 
and wound (7%). The remaining isolates were distributed among blood (3%), bronchial 
washing (3%), ear (3%), bile (2%), pleural fluid (1%), catheter (1%), urethral discharge 
(1%), and other tissues (2%).  The 100 isolates were recovered from 51 female patients and 
49 males of all age categories including 41 seniors, 34 adults, 8 youth, 11 children, and 6 
neonates. The samples were streaked on Tryptone Soy Agar (TSA) and stored in 
Cryobanks at -80°C (Issa, 2008).  
 
 
3.2 Molecular Typing of P. aeruginosa by PFGE  
 
 
Preparation of genomic DNA of the 100 isolates was performed as described in the 
ARPAC PFGE protocol (http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/119494 
7324361). All isolates are digested with SpeI (Roche), and the resulting fragments are 
separated by electrophoresis on 1.2% agarose gels with a CHEF DR III apparatus (Bio-
Rad) at 14°C, 5.9 V/cm, for 22 h, with a time switch of 5 to 50 s in 0.5× Tris-borate EDTA 
(TBE) buffer containing 50 μM thiourea. The 48.5 kb lambda ladder (Bio-Rad) was used as 
the molecular weight marker. The gels were stained with ethidium bromide (EtBr) and their 
photographic images were saved as TIFF files.  
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3.2.1 Dendrogram and PFGE pattern analysis 
 
 
Gel densitometric analysis was performed by GelCompar II software (Applied Maths) 
where the band patterns are compared by the use of the Dice coefficient and the unweighted 
pair group method (optimization of 0.5% and band tolerance of 1.25%) to determine band 
similarity and to define the pulsed-field type clusters. Isolates with band patterns that are 
100% identical are considered to be of identical PFGE types, and isolates that had band 
patterns with ≥87% similarity are considered to be genetically related. 
 
 
3.3 Antibiotic Susceptibility Test 
 
 
All P. aeruginosa isolates and a standard culture ATCC 27853 were tested by the agar disc 
diffusion method against antibiotics (aztreonam, carbencillin, ceftazidime, imipenem, 
pipercillin/tazobactam, and tetracycline) according to Clinical and Laboratory Standards 
Institute (CLSI, 2010). 
 
3.4 Biofilm Formation of P. aeruginosa 
 
3.4.1 Preparation of P. aeruginosa suspensions 
 
The cryobanked strains were initially inoculated onto TSA plates and incubated at 37°C for 
24 h. Tryptone soya broth (TSB) was inoculated with a full loop of culture and placed in a 
shaker-incubator at 37°C and 180 rpm. After overnight incubation, a suspension equivalent 
to 0.5 McFarland (10
8
 CFU/ml) was diluted to prepare a working culture of 10
5
 CFU/ml in 
15 ml of suspension into a 50-mL sterile polypropylene centrifuge tube, as described in the 
protocol (Haddadin, Saleh, Mahmoud, & Shehabi, 2010). 
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3.4.2 Preparation of test surfaces 
 
 
Stainless steel tiles (Type 316, 22 × 22 mm, 1 mm thickness) were washed with detergent, 
rinsed with distilled water and sterilized by storing them in ethanol (70%). 
 
 
3.4.3 Measuring the attachment strength of P. aeruginosa strains 
 
 
Each tile was placed vertically in a 50 ml sterile polypropylene centrifuge tube containing 
15 mL of P. aeruginosa TSB suspensions (10
5
 CFU/ml of bacteria). After 2 min, the tiles 
were removed aseptically and rinsed in 3 successive 20 mL volumes of sterile saline 
(0.9%). After rinsing, the tiles were removed with forceps and placed gently, flat on the 
surface of TSA plate. After one min, the tiles were removed to a second plate and the first 
plate was spread with a glass spreader. The process was repeated through a succession of 
10 TSA plates. Colony counts were determined after overnight incubation at 37°C.  
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Chapter Four 
RESULTS 
 
 
4.1 Antibiotic Susceptibility Test 
 
 
 
The 100 clinical isolates of P. aeruginosa were distributed into 32 antibiotypes. Annex 3 
shows the percentage of isolates belonging to each antibiotype as well as their 
corresponding antibiotic susceptibility profiles. Results showed that 95% of the samples are 
resistant to tetracycline, 49% to carbenicillin, 28% to aztreonam, 25% to 
piperacillin/tazobactam, 23% to ceftazidime, and 20% to imipenem (Figure 1). Multidrug 
resistance was also detected with 3% being susceptible to all the 6 antibiotics tested, 42% 
are resistant to only 1 antibiotic, 21% resistant to 2, 8% to 3, 4% resistant to 4, 16% 
resistant to 5, and 6% resistant to all the 6 tested antibiotics (Figure 2).  
 
 
4.1.1 Resistance versus Site of Infection 
 
 
P. aeruginosa clinical isolates utilized in this study were recovered mainly from tracheal 
aspirates (28%), urine (21%), sputum (16%), pus (11%), and wound (7%). Other sites of 
infection of P. aeruginosa were bile, ear, blood, catheter, pleural fluid, bronchial washing, 
and other tissues (Annex 1). Among the 55 isolates that are multidrug resistant, 38% were 
tracheal aspirates, 16% urine, 13% sputum, 11% were wound and pus each, 3.5% were bile 
and ear, and 2% were catheter and bronchial washing each (Figure 3).  
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4.1.2 Resistance versus Presence of exoS and exoU Toxin Genes 
 
 
Issa (2008) showed that 44% of the 100 P. aeruginosa clinical isolates harbored only exoS 
toxin gene, another 45% harbored only the exoU toxin gene, 3% carry both toxin genes, 
while 8% have none. Sixteen percent of the isolates that harbored exoS toxin gene were 
resistant to 5 of the antimicrobials tested, and 4.5% were resistant to the 6 tested antibiotics. 
However, 15.5% of the isolates that carry the exoU toxin gene were resistant to 5 
antibiotics, while 7% resistant to all 6 (Figure 4). 
 
 
4.2 Strength of Attachment of P. aeruginosa to Stainless Steel Surfaces 
 
 
The blot succession technique performed on the 100 clinical isolates of P. aeruginosa, 
showed that after the 2 minutes incubation of the stainless steel tiles in 10
5
 CFU/ml of 
bacterial suspension, the number of colonies grown on TSA decreased with each successive 
plating. Annex 4 shows the initial attachment of each isolate and the number of colonies in 
the successive plating. Some isolates did not show initial attachment ability, such as 
PA154, while other samples not only have a strong initial attachment, but also maintain 
such strength even after the succession of the last plate, such as PA4 (Figure 5). 
 
 
4.3 PFGE and Dendrogram Analysis 
 
 
The 100 P. aeruginosa samples were run on PFGE apparatus and their corresponding 
restriction patterns were compared and analyzed by constructing a phylogenetic tree 
(Figure 8). None of the isolates were genetically identical with 100% similarity index. 
Eighty-three isolates were found to be genetically different where less than 80% band 
similarity was detected, according to the criteria developed by Tenover et al. (1995). The 
remaining 16 isolates were classified in clones that belonged to different subgroups. Figure 
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6 represents the fingerprinting of 10 isolates as an example of the uniqueness of each. One 
of the isolates could not be determined, while the remaining 99 isolates revealed the 
presence of two major groups (I and II), one of which contained only 2 isolates. The second 
major group (II) consisted of 8 subgroups (represented from A to H) where C, F, G and H 
further divide into 2 clones each (C1, C2, F1, F2, G1, G2, H1 and H2) (Figure 7). 
 
P. aeruginosa isolates recovered from the respiratory tract, such as tracheal aspirates and 
sputum, belonged to subgroup II-G. Isolates recovered from urine formed 47% of II-C, 
while 13% of isolates from pus were subgrouped into II-H (Table 1).  Other sites of 
infection recovered in this study were sporadically distributed. The majority (80%) of the 
isolates in II-B harbored exoU toxin gene.  
 
 
4.4 Biotypes 
 
Hundred P. aeruginosa clinical isolates were distributed among 10 biotypes classified 
according to differences in morphological characteristics (Annex 5) (Issa, 2008).  
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Figure 1: Percentage of P. aeruginosa isolates that are resistant to each of the 6 antibiotics tested, 
imipenem (IPM), carbenicillin (CAR), piperacillin/tazobactam (TZP), tetracycline (TE), 
aztreonam (ATM), and ceftazidime (CAZ), by measuring the inhibition zone of the disc 
diffusion susceptibility test. 
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Figure 2: Distribution of multidrug resistance among P. aeruginosa clinical isolates. 
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Figure 3:  Distribution of infection sites of the P. aeruginosa isolates that are multidrug resistant to 
more than 1 antibiotic tested. Thirty-eight percent were recovered from tracheal aspirates, 
16% from urine, 13% from sputum, 11% from each of wound and pus, 3.5% from each of 
bile and ear, and 2% from each of catheter and bronchial washing. 
 
0
5
10
15
20
25
30
35
40
45
50
%
 o
f 
re
s
is
ta
n
t 
is
o
la
te
s
No. of antibiotics
exoS 4.5 45.5 18 7 4.5 16 4.5
exoU 0 42 24.5 9 2 15.5 7
0 1 2 3 4 5 6
 
 
Figure 4: Percentage of resistant isolates harboring exoS or exoU as a function of number of antibiotics 
they are resistance to.   
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Figure 5: Number of colonies grown as a function of plate succession number for 3 isolates (PA4, 
PA124, and PA154) selected as an example of variation in strength of attachment of P. 
aeruginosa strains.  
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Figure 6:  PFGE gel displaying restriction patterns of 10 representative P. aeruginosa clinical 
isolates, PA 29, PA 32, PA 34, PA 36, PA 37, PA 43, PA 44, PA 45, PA 47 and PA 51 cut 
by SpeI. Lanes 1, 7, and 13 represent BioLab Lambda marker that has a size range of 
48.5 kb to 1,018.5 kb. 
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Figure 7: Dendrogram of PFGE patterns of P. aeruginosa isolates generated with the Gel Compar II 
software showing two major groups (I and II), where (I) contained 2 isolates. The second 
major group (II) consisted of 8 subgroups (A to H) where C, F, G and H further divide into 2 
clones each (C1, C2, F1, F2, G1, G2, H1 and H2). The scale indicates percent similarity.  
 
 
 
 
Table 1: Distribution of P. aeruginosa isolates among the 2 major PFGE groups (I and II) and 
subgroups (A to H) based on the site of infection (tracheal aspirates, sputum, urine, and pus), 
and detected exotoxins genes (exoS and exoU).  
 
PFGE 
Group 
PFGE 
Subgroup 
Total number 
of isolates per 
group 
Site of infection Exotoxins 
Tracheal 
aspirates 
Sputum Urine Pus exoS exoU 
I  2 1 (50) - - 1 (50) 1 (50) 1 (50) 
II A 3 - 1 (33) 1 (33) - 2 (67) 1 (33) 
 B 5 1 (20) 1 (20) 2 (40) - 1 (20) 4 (80) 
 C 15 2 (13) 2 (13) 7 (47) 1 (7) 6 (40) 9 (60) 
 D 4 - - 1 (25) 1 (25) 2 (50) 2 (50) 
 E 2 - 1 (50) 1 (50) - 1 (50) 1 (50) 
 F 32 11 (34) 4 (13) 5 (16) 3 (9) 18 (56) 13 (41) 
 G 13 7 (54) 3 (23) 1 (8) 1 (8) 7 (54) 5 (38) 
 H 23 6 (26) 4 (17) 1 (4) 3 (13) 8 (35) 12 (52) 
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Figure 8: Dendrogram of PFGE macrorestriction patterns of P. aeruginosa isolates generated with the 
Gel Compar II software. The scale indicates percent similarity. 
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Chapter Five 
DISCUSSION 
 
Antibiotic resistance in P. aeruginosa has developed through several mechanisms and is a 
major problem challenging clinical settings. In this study, 95% of P. aeruginosa isolates 
were resistant to tetracycline, which is the highest percentage among the other 
antimicrobials tested (Figure 1). This increased tolerance to tetracycline is explained by low 
permeability of bacterial outer membrane (Dubois et al., 2008). Recent studies have shown 
that the efflux system is an effective resistance mechanism of most antibiotics (Adwan, 
Abu-Shanab, & Adwan, 2009). Efflux pumps can recognize and remove wide range of 
antibiotic classes because efflux proteins, such as Mex proteins, are not specific to 
particular drugs (Kumar & Schweizer, 2005). This mechanism could explain the multidrug 
resistance phenomenon of P. aeruginosa where 22% of the isolates were resistant to five or 
to all of the six antimicrobials tested in this study. Furthermore, selective pressure and 
multiple mutations may up-regulate multidrug resistance systems in P. aeruginosa (Alonso, 
Campanario, & Martinez, 1999). 
 
In this study, P. aeruginosa isolates were recovered from different sites with the trachea 
comprising 28% of the samples, 2 out of which were resistant to all tested drugs. Two out 
of the 16 isolates recovered from sputum were also multidrug resistant. Moreover, 4 
isolates recovered from tracheal aspirates, and 3 from each of urine and pus samples 
showed resistance to 5 out of the 6 tested antimicrobial agents. These results were in 
harmony with those reported by Wong-Beringer, Wiener-Kronish, Lynch, and Flanagan 
(2008), who indicated that the respiratory tract not only was it a main site of infection of P. 
aeruginosa, but also isolates recovered were highly resistant. Urine and pus, as well, 
exhibited a niche for these pathogenic bacteria which in turn were resistant to most of the 
tested antibiotics.  
 
Within the isolates being positive to exoS and exoU, 20.5% harboring exoS and 22.5% were 
resistant to at least 5 of the tested antimicrobial agents (Figure 4). Isolates that produce 
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ExoU protein are able to evade host immune response at the beginning of the infection 
period while those producing ExoS protein can decrease DNA synthesis (Wong-Beringer et 
al., 2008). This indicates that the presence of virulence factors, such as the toxin genes, 
enhances the tolerance of P. aeruginosa in the host, and thus necessitates extensive 
antimicrobial treatment. Therefore, antibiotic resistance develops due to selective pressure 
exerted by the toxins produced.     
 
The genotypic typing method used in this study and that offered insight of genetic variation 
was PFGE. PFGE shows restriction site polymorphism and provides a genome-wide 
viewpoint on diversity, unlike other molecular typing methods such MLST that shows 
nucleotide polymorphism and gives robust information of core genome evolutionary 
changes. In other words, PFGE shows different pattern types of different strains arising 
from point mutations, inter- or intragenomic recombination events, however MLST 
generates different sequence types (ST) from genetic variation of only the targeted loci of 
specific housekeeping genes that have slow clock speed (Waine et al., 2009). In this study, 
PFGE was performed on 100 P. aeruginosa clinical isolates where it displayed significant 
discriminatory power and typeability. Of the 99 isolates of determined PFGE profiles, none 
was genetically identical to another, none having 100% similarity index, suggesting the 
presence of 99 PFGE types (PTs). Eighty-three isolates were found to be genetically 
different, according to the criteria developed by Tenover et al. (1995) having less than 80% 
band similarity. The remaining 16 isolates were classified in clones that belonged to 
different subgroups. Consistent with other studies, such heterogeneity indicates endogenous 
origin of Pseudomonas infections of unrecognized molecular clusters (Bertrand et al., 
2001; Waters et al., 2004). Moreover, very closely related isolates, having more than 90% 
genetic similarity index, belong to the same patient, such as PA96 and PA106 recovered 
from sputum and bronchial washing respectively from one patient, as well as PA44 and 
PA51 recovered from tracheal aspirates of another patient. This indicates that the patients 
being admitted were not harboring or acquiring other clones of the P. aeruginosa species, a 
result reported in a previous study by Heo, Haase, Lesse, Gill, and Scannapieco (2008). 
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Most P. aeruginosa isolates have distinct genotypes confirming that molecular typing 
methods have a better resolving power than phenotypic ones, such as classification based 
on morphological characteristics, referred as biotypes, or antimicrobial susceptibility tests, 
referred as antibiotypes. A previous study performed on the same 100 P. aeruginosa 
clinical isolates revealed the categorization of these samples into 10 biotypes (Issa, 2008). 
However, molecular typing such as DNA restriction pattern analysis showed that most P. 
aeruginosa isolates belonged to different genotypes, confirming the better discriminatory 
power of this method compared to biotyping, a result that concord with a study by Freitas 
and Barth (2004). Furthermore, the low discriminatory ability of antibiogram profiles is 
expected because the typeability is considered strong when higher numbers of types are 
recognized by a certain method as well as lower frequencies of each type. We obtained 
sufficient number of types (32 antibiotypes), however the distribution of the isolates among 
these types (25% belong to the same antibiotype) indicated the reduced ability of the 
antibiogram to distinguish between P. aeruginosa strains. Moreover, 32 antibiotypes versus 
99 PTs confirmed better discrimination through genotyping. In concordance with Johnson 
et al. (2007), PFGE has not classified the isolates according to their resistance to imipenem 
and piperacillin-tazobactam. In addition, the inability of antibiotype to verify clonal 
relatedness among isolates has been previously reported (Freitas & Barth 2004).  
 
Finding a correlation between PFGE patterns and site of infection could be of interest 
especially with outbreak cases. However, in this study, where molecular typing showed 
vast differences among P. aeruginosa samples, it was unlikely to find a strong correlation 
between the PFGE subgroups and site of infection. Nevertheless, subgroup II-G consisted 
of 13 isolates, among which 7 were recovered from tracheal aspirates, 3 sputum, and 1 
bronchial washing. Accordingly, 11 out of the 13 isolates that belonged to II-G had 
colonized the respiratory tract of patients. This indicates a strong correlation between 
respiratory tract recovered P. aeruginosa strains and cluster II-G. It should be taken into 
consideration that respiratory tract infections in hospital settings, mainly ventilator-
associated pneumonia (VAP), caused by P. aeruginosa, was previously reported to be the 
most common infection type in intensive care units (ICU) (Agodi et al., 2007). 
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Furthermore, 7 out of 15 II-C isolates (47%) were recovered only from urine samples 
(Table 1), which was another correlation between PFGE clusters and site of colonization. 
Other sites of infection, such as wounds, ear, blood, and catheter were sporadic among the 
subgroups. However, such isolates were few in number, hence data may not be sufficient to 
correlate with their corresponding PFGE profiles.  
 
PFGE patterns were also correlated with the presence of toxins in the studied Pseudomonas 
strains. Although 80% of isolates clustered in II-B and harbored exoU toxin gene, the total 
number of isolates in II-B was only 5; thus the number was too low to be considered as a 
reliable correlation between the 2 parameters. Other correlations between PFGE profiles 
and the presence of exotoxins genes were not notably detected. 
 
The ability of P. aeruginosa to adhere to surfaces and form a thick impermeable layered 
structure, known as biofilm, is considered one of its strong virulence factors in hospitals 
(Smith & Hunter, 2008). The persistence of this pathogen in the environment through 
biofilm formation increases its resistance to biocide treatments (Bridier et al., 2011). 
Biofilm formation occurs in a sequence of stages. It begins with the attachment of bacterial 
cells, microcolonies formation, and then maturation of the microcolonies into mushroom-
like arrangements. Later, the entire structure can detach (Banin et al., 2005). In this study, 
we focused on the first stage of biofilm formation in order to examine the strength of 
attachment, knowing that P. aeruginosa can adhere to stainless steel surfaces within only 
30 seconds (Haddadin et al., 2010). In this study, the incubation time of the bacterial 
suspension with the stainless steel tiles was 2 minutes to provide adequate time for the 
isolates to colonize the surfaces. Alginate is a major component of the biofilm glycocalyx 
in Pseudomonas and plays an essential role during the attachment stage. It is encoded by 
algACD cluster that are overexpressed after 15 minutes of contact to glass surface (Dunne, 
2002). Many P. aeruginosa isolates showed strong attachment to stainless steel tiles within 
2 minutes of incubation; PA4 isolate had an initial attachment of 981 colonies, and 
maintained this relatively high colony count even on the tenth plate. This indicated that 
some P. aeruginosa strains have the ability to strongly adhere to surfaces of tissues and 
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contaminate medical equipments, helping Pseudomonas infections to spread. On the other 
hand, some isolates, such as PA124, had a stronger initial attachment where almost 1104 
colonies have grown on the first plate, however, the number of colonies have declined to 10 
on the last plate. Other isolates had a very low colony count from the very beginning of the 
blot succession technique with PA154 having only 3 colonies on the first plate (Figure 5). 
This indicated a weak attachment ability of these strains to surfaces, and presented no 
danger of spreading P. aeruginosa infections through adherence to medical equipments. 
Another interpretation might be that such isolates need more time to adhere to surfaces.      
 
Many studies have sought a relationship between multidrug resistance and P. aeruginosa 
biofilm formation. The presence of alginate in Pseudomonas biofilms enhances the 
multidrug resistance by binding and inactivating the antimicrobials and acting at the same 
time as an impermeable barrier (Hoiby et al., 2001; Drenkard, 2003). Drenkard and 
Ausubel (2002) have found that some P. aeruginosa variants have greater adherence 
capability to glass or polyvinyl chloride (PVC) and developed stronger biofilms. These 
strains have resistance to β-lactams and tetracycline. However, Bratu, Gupta, and Quale 
(2006) revealed that no correlation exists between the activation of quorum sensing genes, 
which are required for successful formation of a biofilm structure, and expression of an 
efflux system, required for antibiotic resistance. This study compared the samples that are 
resistant to all the tested antibiotics with results obtained from blot succession. 
Accordingly, two multidrug resistant isolates, PA4 and PA16, showed strong initial 
attachment (981 and 629 colonies respectively) and maintained high numbers in the 
successive plates. In contrast, PA59 and PA70 displayed weak attachment ability (87 and 
84 colonies respectively) despite their resistance to the 6 antimicrobial agents tested. Most 
of the samples that also showed resistance to 5 antimicrobials exhibited moderate to high 
initial attachment strength. In contrast, PA154 and PA156, have weak attachment strength 
although resistant to 5 antibiotics. On the other hand, isolates that belong to the same 
antibiotype and hence had identical resistance profiles had showed differences in their 
attachment profiles; PA93, PA110, and PA112, which exhibited resistance only to 
tetracycline, had similar high initial attachment strength (769, 580, and 682 colonies 
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respectively), unlike PA103 and PA170, which belonged to antibiotype number 5, had very 
weak initial attachment strength (32 and 20 colonies respectively). Initial attachment 
depends on the concentration of the bacterial suspension and on the properties of the 
stainless steel tiles used, which would influence the degree of bacterial contact to the tiles 
and hence their growth onto TSA plates (Gottenbos, van der Mei, Busscher, 2000). In 
agreement with a previous study (Haddadin et al., 2010), the overall results of this 
experiment indicated a weak correlation between initial attachment strength and multidrug 
resistance for P. aeruginosa clinical samples.  
 
 
In this study, we employed PFGE as a highly discriminatory molecular typing method for 
the characterization of P. aeruginosa where none of the samples were genetically identical. 
The obtained data allow us to better understand the evolution and epidemiology of P. 
aeruginosa in Lebanon. High levels of multidrug resistance in P. aeruginosa infections 
propose the necessity of an inspection program to prevent colonization and dissemination 
of antimicrobial resistant bacteria, as well as the monitoring of antibiotic use. Biofilm 
formation is another important aspect of this pathogen, where strong initial attachment of 
bacteria to surfaces was detected. 
 
As future work, MLST is recommended as a molecular typing method, due to its slower 
clock speed than PFGE, to confirm or narrow down the vast genetic diversity of P. 
aeruginosa obtained by PFGE. It is also recommended to test antibiotic resistance on 
biofilm forming bacterial cells, for the fact that P. aeruginosa biofilms contribute to higher 
resistance to antimicrobial treatments than their planktonic counterparts. Furthermore, the 
effect of quorum-sensing deficiency on biofilm formation may be investigated as well. 
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Chapter Six 
CONCLUSION 
 
 
 This study employed PFGE as a molecular typing method for the epidemiological 
characterization of P. aeruginosa clinical samples.  
 
 The phylogenetic tree revealed the presence of two major groups (I and II), where 
group I contained only 2 isolates. The second major group (II) consisted of 8 
subgroups (represented from A to H) where C, F, G and H further divide into 2 
clones each. Samples were not genetically identical confirming the heterogeneity 
and endogenous origin of Pseudomonas infections of unrecognized molecular 
clusters. 
 
 A strong correlation was detected between respiratory tract P. aeruginosa strains 
and the cluster II-G of certain restriction patterns. In addition to a moderate 
correlation between urine samples and PFGE cluster II-C. 
 
 No correlation was detected between PFGE profiles and the presence of exotoxins 
genes. 
 
 Antimicrobial susceptibility testing showed the distribution of the P. aeruginosa 
samples into 32 antibiotypes. Resistance was a concern where only 3% of the 
isolates were susceptible to all the 6 antibiotics tested. Multidrug resistance to 6 
antimicrobials comprises 6% of the strains, followed by 16% being resistant to 5 
antimicrobials. 
 
 
 Most P. aeruginosa displayed resistance to tetracycline (95%) and carbenicillin 
(49%), while being susceptible to imipenem (20%) and ceftazidime (23%).  
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 Many P. aeruginosa isolates showed strong attachment to stainless steel tiles within 
2 minutes of incubation and maintained such attachment at successive stages, 
signifying the ability of this pathogen to strongly adhere to tissue surfaces and 
contaminate medical equipments. Some strains had a weak ability to attach to 
surfaces, and presented no danger of spreading P. aeruginosa infections through 
adherence to medical equipments. 
 
 A weak correlation has been detected between multiple drug resistance and strength 
of attachment to surfaces.  
 
 Antibiotic susceptible P. aeruginosa could have the potential of attaching strongly 
to surfaces and hence forming biofilm. 
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ANNEX 
 
 
Annex 1: Demographics of the 100 P. aeruginosa clinical isolates collected from 
American University of Beirut Medical Center (AUBMC). 
 
Strain Gender Age Site of infection Date 
3 F 85 fluid pleural tap 28/03/2007 
4 M 60 bile 02/04/2007 
5 M 60 urine 07/04/2007 
9 M 77 catheter 27/03/2007 
14 M 78 Tracheal aspirate 29/04/2007 
15 F 82 Tracheal aspirate 24/04/2007 
16 F 82 Tracheal aspirate 20/04/2007 
17 F 22M swab, ear 20/04/2007 
19 F 66 Tracheal aspirate 06/11/2007 
20 M 50 Pus 20/04/2007 
21 F 5 Tracheal aspirate 30/04/2007 
25 M 47 Urine 03/05/2007 
26 F 85 Tracheal aspirate 30/04/2007 
28 F 62 Tracheal aspirate 09/05/2007 
29 M 4 Wound 02/05/2007 
32 M 23 Pus 05/05/2007 
34 F 31 Ear 03/05/2007 
36 M 58 Other 18/06/2007 
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37 F 21M Sputum 10/05/2007 
43 F 5 Tracheal aspirate 31/05/2007 
44 M 37 Tracheal aspirate 30/05/2007 
45 M 22 Tracheal aspirate 03/06/2007 
47 F 19 Pus 22/05/2007 
51 M 37 Tracheal aspirate 31/05/2007 
53 F 82 Tracheal aspirate 28/05/2007 
59 M 58 Sputum 26/6/2007 
60 F 69 Tracheal aspirate 25/06/2007 
61 M 72 Bronchial washing 23/06/2007 
62 M 71 Tracheal aspirate 27/06/2007 
63 F 33 Pus 27/06/2007 
64 M 71 Tracheal aspirate 22/06/2007 
65 M 82 Tracheal aspirate 13/06/2007 
67 F 68 Tracheal aspirate 16/06/2007 
68 M 22 swab-pus 13/06/2007 
69 M 15M Tracheal aspirate 14/06/2007 
70 M 58 Sputum 14/06/2007 
72 M 51 Urethral discharge 19/06/2007 
93 F 77 Urine 26/8/2007 
94 M 72 Sputum 09/09/2007 
95 M 61 Sputum 09/10/2007 
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96 M 57 Sputum 09/10/2007 
97 F 72 Urine 09/08/2007 
98 M 68 Urine 09/05/2007 
99 F 31 Pus 09/01/2007 
100 M 74 Sputum 09/11/2007 
102 M 53 Urine 09/09/2007 
103 F 7W Urine 17/09/2007 
104 M 72 Bronchial washing 16/09/2007 
105 F 57 Urine 17/09/2007 
106 M 57 bronchial washing 16-09-2007 
107 F 2M Tracheal aspirate 15/09/2007 
108 F 16 Pus 17/09/2007 
109 F 3M Urine 19/09/2007 
110 F 84 Urine 18/09/2007 
111 F 37 Urine 21/09/2007 
112 F 3M Blood 24/09/2007 
113 F 1Y Urine 25/09/2007 
116 F 21 Pus 10/01/2007 
118 F 2Y Tracheal aspirate 10/03/2007 
119 M 7W Urine 10/04/2007 
120 F 3 Tracheal aspirate 10/02/2007 
121 F 10 Urine Oct 2007 
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122 M 51 Sputum 10/09/2007 
123 F 86 Urine Oct 2007 
124 F 30 Urine 13/10/2007 
125 F 72 Wound 13/10/2007 
126 F 3 Tracheal aspirate 10/10/2007 
132 M 71 Blood 10/09/2007 
133 M 7W Urine Oct 2007 
135 F 77 Urine Oct 2007 
137 F 63 Blood 10/09/2007 
138 F 60 Bile 10/08/2007 
139 F 63 Urine Oct 2007 
140 M 38 Wound 17/10/2007 
141 M 85 Sputum 10/11/2007 
142 F 75 Urine Oct 2007 
144 F 70 Sputum 13/11/2007 
147 F 76 tissue, other 11/09/2007 
148 F 46 Sinus 11/12/2007 
152 M 68 Urine 11/08/2007 
154 M 73 Pus 24/10/2007 
155 M 47 Tracheal aspirate 11/03/2007 
156 F 68 Wound 02/04/2008 
157 F 77 Tracheal aspirate 30/10/2007 
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158 F 90 Pus 30/10/2007 
159 M 80 Tracheal aspirate 31/10/2007 
160 M 21 Wound 11/02/2007 
161 M 79 Sputum 27/10/2007 
162 F 38 Pus 13/11/2007 
163 M 47 Wound 26/10/2007 
166 F 65 Sputum 11/07/2007 
167 M 70 Sputum 11/06/2007 
168 M 47 Tracheal aspirate 11/06/2007 
169 M 79 Sputum 11/03/2007 
170 F 44 Ear 11/04/2007 
172 M 22 Sputum 27/11/2007 
174 F 63 Sputum 29/11/2007 
175 M 47 Tracheal aspirate 29/11/2007 
176 M 72 Tracheal aspirate 27/11/2007 
177 M 76 Wound 27/11/2007 
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Annex 2: Antibiotic susceptibility profiles for the 100 clinical isolates of P. aeruginosa  
and their antibiotypes. (R: resistant; I: intermediate; S: susceptible). 
 
Sample no. IPM CAR TZP TE ATM CAZ Antibiotype 
PA3 S I S R I S 5 
PA4 R R R R R R 32 
PA5 R R S R R R 26 
PA9 I R R R I S 18 
PA14 S I S R I S 5 
PA15 R R R R I R 27 
PA16 R R R R R R 32 
PA17 S R S R I S 12 
PA19 R I S R I S 13 
PA20 R R S R R S 22 
PA21 S R S R I S 12 
PA25 S I S R I S 5 
PA26 S R S R I S 12 
PA28 R R R R I R 27 
PA29 S S S R R I 14 
PA32 I R R R R R 28 
PA34 S R R R R R 29 
PA36 S I S R I S 5 
PA37 R R S R I I 19 
PA43 S I S R S S 6 
PA44 S R S R R S 20 
PA45 R R R R R R 32 
PA47 S I S R I S 5 
PA51 S R S R R S 20 
PA53 R R R R S R 30 
PA59 R R R R R R 32 
PA60 S R S R I S 12 
PA61 S R S R I S 12 
PA62 S I S S I S 2 
PA63 S I S R I S 5 
PA64 S S S S S S 1 
PA65 S I S R I S 5 
PA67 S S S S I S 3 
PA68 S R R R R R 29 
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PA69 R R R I R R 31 
PA70 R R R R R R 32 
PA72 I I S R I S 7 
PA93 S I S R I S 5 
PA94 S I S R I S 5 
PA95 S I S R I S 5 
PA96 S S S R S S 8 
PA97 S R R R R R 29 
PA98 S S S R I S 9 
PA99 S I S R I S 5 
PA100 S I S R R S 15 
PA102 R S S R S S 16 
PA103 S I S R I S 5 
PA104 S I S R I S 5 
PA105 S I S R S S 6 
PA106 S S S R I S 5 
PA107 S I S R I S 5 
PA108 S S S R I S 9 
PA109 S R R R R R 29 
PA110 S I S R I S 5 
PA111 S S S R I S 9 
PA112 S I S R I S 5 
PA113 S S S R I S 9 
PA116 S R S R I S 12 
PA118 S R S R R S 20 
PA119 S S S R I S 9 
PA120 I I S R R I 17 
PA121 S R S R I S 12 
PA122 S R S S I S 4 
PA123 S I S R I I 10 
PA124 R R S R I S 21 
PA125 S R S R I S 12 
PA126 R I S R I S 13 
PA132 S I S R I S 5 
PA133 S I S R I S 5 
PA135 S R R R I R 23 
PA137 S I S R I S 5 
PA138 S R R R R R 29 
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PA139 S S S R S S 8 
PA140 S R S R I S 12 
PA141 S R R R R R 29 
PA142 S R S R I S 12 
PA144 S S S R S I 11 
PA147 S I S R I S 5 
PA148 S S S R I S 9 
PA152 R R R R R R 32 
PA154 S R R R R R 29 
PA155 R R S R I S 21 
PA156 S R R R R R 29 
PA157 R I S R I S 13 
PA158 S I S R I S 5 
PA159 S R R R R I 24 
PA160 S R R R R R 29 
PA161 S R R R R R 29 
PA162 S R S R I S 12 
PA163 S S S R I S 9 
PA166 S I S R I S 5 
PA167 I R R R R I 25 
PA168 S R S R I S 12 
PA169 S I S R S S 6 
PA170 S I S R I S 5 
PA172 S I S R I S 5 
PA174 S S S R S S 8 
PA175 R R S R I S 21 
PA176 S R S R I S 12 
PA177 S R S R I S 12 
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Annex 3: Antibiotic susceptibility profile of each of the 32 antibiotypes and the 
percentage of isolates belonging to each antibiotype. 
 
Antibiotype IPM CAR TZP TE ATM CAZ 
No. of 
Resistant 
AB 
% 
isolates 
1 S S S S S S 0 1 
2 S I S S I S 0 1 
3 S S S S I S 0 1 
4 S R S S I S 1 1 
5 S I S R I S 1 25 
6 S I S R S S 1 3 
7 I I S R I S 1 1 
8 S S S R S S 1 3 
9 S S S R I S 1 7 
10 S I S R I I 1 1 
11 S S S R S I 1 1 
12 S R S R I S 2 14 
13 R I S R I S 2 3 
14 S S S R R I 2 1 
15 S I S R R S 2 1 
16 R S S R S S 2 1 
17 I I S R R I 2 1 
18 I R R R I S 3 1 
19 R R S R I I 3 1 
20 S R S R R S 3 3 
21 R R S R I S 3 3 
22 R R S R R S 4 1 
23 S R R R I R 4 1 
24 S R R R R I 4 1 
25 I R R R R I 4 1 
26 R R S R R R 5 1 
27 R R R R I R 5 2 
28 I R R R R R 5 1 
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29 S R R R R R 5 10 
30 R R R R S R 5 1 
31 R R R I R R 5 1 
32 R R R R R R 6 6 
 
 
        Annex 4: Blot succession technique results of the 100 clinical isolates of P. aeruginosa. 
 
Strain Plate succession number 
 1 2 3 4 5 6 7 8 9 10 
PA3 153 49 38 7 8 5 3 4 3 1 
PA4 981 776 702 544 315 239 190 172 160 166 
PA5 315 79 73 20 16 16 17 9 3 3 
PA9 638 348 395 311 288 221 104 84 30 19 
PA14 344 124 66 48 44 26 31 21 15 11 
PA15 372 215 44 47 13 15 14 6 10 6 
PA16 629 630 468 410 266 193 62 14 17 14 
PA17 371 253 178 115 87 66 54 47 32 30 
PA19 659 378 144 67 34 12 9 5 2 2 
PA20 270 192 154 100 83 30 42 16 10 7 
PA21 309 276 56 59 16 15 19 6 4 2 
PA25 140 113 28 4 1 5 1 1 0 1 
PA26 423 407 138 65 40 39 27 23 15 17 
PA28 922 652 537 404 140 61 47 24 11 15 
PA29 759 524 381 284 106 80 72 29 19 19 
PA32 658 217 138 62 37 21 14 10 7 4 
PA34 492 480 439 140 60 24 14 1 2 0 
PA36 980 556 242 84 19 10 2 2 1 1 
PA37 906 571 196 74 37 21 9 12 8 3 
PA43 870 434 300 75 52 42 35 26 15 6 
PA44 447 324 311 152 89 52 36 26 12 15 
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PA45 219 186 172 140 154 88 49 42 37 31 
PA47 258 80 52 18 13 4 7 3 2 0 
PA51 284 237 181 187 147 135 66 37 28 23 
PA53 233 205 159 139 81 78 22 20 18 20 
PA59 87 65 52 26 19 11 7 9 4 2 
PA60 26 12 3 7 0 0 1 1 0 0 
PA61 183 189 66 45 19 6 5 3 1 0 
PA62 747 231 97 56 49 16 9 11 9 4 
PA63 433 61 35 22 13 8 7 7 5 2 
PA64 294 133 120 108 95 32 29 25 23 24 
PA65 357 240 161 117 105 115 87 80 61 54 
PA67 197 47 18 13 7 1 1 0 0 0 
PA68 278 175 93 78 74 53 31 31 26 14 
PA69 85 36 39 9 3 5 3 1 1 1 
PA70 84 37 38 35 26 19 12 9 10 2 
PA72 156 46 14 12 12 11 4 3 1 0 
PA93 769 418 148 93 45 29 32 16 17 12 
PA94 621 220 171 154 102 72 23 30 16 8 
PA95 171 113 68 30 18 8 6 5 2 1 
PA96 60 42 14 4 3 1 2 0 0 0 
PA97 188 105 40 37 13 10 6 7 6 3 
PA98 199 96 39 14 13 11 6 3 0 1 
PA99 261 124 36 9 8 4 2 1 0 1 
PA100 355 73 67 15 8 6 4 5 2 2 
PA102 578 375 146 127 80 49 36 26 23 14 
PA103 32 21 16 10 5 3 1 0 1 0 
PA104 638 168 122 69 50 25 19 13 5 3 
PA105 129 103 70 11 6 3 1 3 0 0 
PA106 319 83 32 20 17 12 9 5 5 3 
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PA107 657 450 397 276 271 158 102 63 40 24 
PA108 796 318 117 68 31 29 26 15 12 13 
PA109 223 88 22 22 18 9 5 4 3 4 
PA110 580 259 130 98 71 32 16 12 4 3 
PA111 460 297 285 186 105 54 50 44 47 39 
PA112 682 533 295 131 70 31 29 17 20 9 
PA113 522 219 90 58 24 15 13 12 6 4 
PA116 534 311 140 97 30 27 17 16 13 5 
PA118 136 39 12 7 6 5 0 1 1 0 
PA119 143 121 67 42 47 23 2 4 2 0 
PA120 321 301 243 208 158 158 41 48 33 18 
PA121 218 116 94 55 25 20 21 20 18 11 
PA122 72 48 51 27 15 7 4 2 0 1 
PA123 218 120 77 25 15 11 6 5 3 5 
PA124 1104 539 461 153 134 50 33 24 14 10 
PA125 840 366 223 82 88 79 48 43 43 25 
PA126 101 39 6 6 4 5 4 1 0 0 
PA132 20 16 14 9 6 3 4 2 1 0 
PA133 68 13 9 4 2 0 1 0 0 0 
PA135 38 26 10 4 3 1 2 1 0 0 
PA137 148 65 47 36 24 22 10 5 1 2 
PA138 131 121 49 25 11 7 2 1 0 0 
PA139 49 20 22 16 6 5 5 2 1 0 
PA140 171 124 99 93 73 68 71 34 26 19 
PA141 455 143 47 18 16 11 7 3 0 0 
PA142 189 75 23 20 11 5 3 6 3 1 
PA144 215 83 34 25 24 23 19 12 7 5 
PA147 96 88 46 28 8 4 4 1 0 0 
PA148 47 46 48 23 20 18 10 7 1 0 
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PA152 194 99 67 52 50 45 26 11 7 5 
PA154 3 3 3 3 2 2 1 0 0 0 
PA155 17 17 8 5 6 4 2 1 0 0 
PA156 88 61 54 50 54 45 37 16 12 11 
PA157 24 21 18 15 6 5 8 2 1 1 
PA158 70 28 14 8 6 7 10 2 1 1 
PA159 52 37 29 26 27 21 17 5 0 1 
PA160 237 181 140 83 73 67 61 58 45 36 
PA161 155 92 60 44 41 42 32 18 12 9 
PA162 54 23 20 16 14 13 9 11 9 7 
PA163 196 53 51 49 28 30 15 18 17 16 
PA166 43 35 33 18 19 5 4 1 0 0 
PA167 200 122 84 33 18 21 19 15 8 7 
PA168 24 18 16 11 8 3 1 0 0 0 
PA169 7 5 1 1 2 1 0 0 0 0 
PA170 20 7 3 0 1 0 0 0 0 0 
PA172 166 83 43 42 35 20 22 10 3 2 
PA174 87 39 28 23 15 13 8 3 5 4 
PA175 31 5 6 2 0 1 1 1 0 0 
PA176 80 53 44 39 14 14 11 9 4 5 
PA177 167 100 91 82 29 21 13 17 15 9 
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Annex 5: Distribution of the isolates in the different biotypes based on their 
morphological characteristics. 
 
Biotypes Samples 
B1 
PA4,PA5,PA14, PA19, PA25, PA34, PA47, PA51, PA62, PA63, PA64, 
PA72, PA97, PA98, PA99, PA104, PA106, PA108, PA110, PA 113, 
PA 119, PA120, PA123, PA124, PA126, PA133, PA135, 
PA139,PA140, PA141, PA142, PA156, PA157, PA158, PA160, 
PA169, PA170, PA172, PA174, PA96, PA148, PA176 
B2 PA100, PA121, PA162 
B3 PA61, PA161, PA67 
B4 
PA15, PA16, PA17, PA65, PA68, PA70, PA93, PA94, PA95, PA103, 
PA107, PA112, PA144, PA147, PA155, PA163, PA167, PA168, PA21, 
PA26, PA29, PA32, PA69, PA102, PA125, PA137, PA159, PA166, 
PA175 
B5 PA3, PA9, PA109, PA154, PA177 
B6 PA44 
B7 PA28, PA43, PA45, PA53, PA59, PA60, PA122 
B8 PA105 
B9 PA118 
B10 PA20, PA36, PA111, PA116, PA132, PA138, PA152 
 
 
